Absorption |
Blood-Brain Barrier | BBB+ | 0.9709 |
Human Intestinal Absorption | HIA+ | 0.9065 |
Caco-2 Permeability | Caco2+ | 0.6771 |
P-glycoprotein Substrate | Non-substrate | 0.8970 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9838 |
Non-inhibitor | 0.9899 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9272 |
Distribution |
Subcellular localization | Lysosome | 0.5639 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8443 |
CYP450 2D6 Substrate | Non-substrate | 0.8270 |
CYP450 3A4 Substrate | Non-substrate | 0.8128 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8473 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8524 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9427 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9051 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9769 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8128 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9569 |
Non-inhibitor | 0.9685 |
AMES Toxicity | Non AMES toxic | 0.9377 |
Carcinogens | Carcinogens | 0.6114 |
Fish Toxicity | High FHMT | 0.6159 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.6546 |
Honey Bee Toxicity | High HBT | 0.8375 |
Biodegradation | Not ready biodegradable | 0.5618 |
Acute Oral Toxicity | III | 0.5797 |
Carcinogenicity (Three-class) | Non-required | 0.5270 |